Catalyst Wire Dossier Catalyst Wire Dossier

Autologous bone marrow-derived mononuclear cells

bone marrow-derived mononuclear cells
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Autologous bone marrow-derived mononuclear cells, covering 2010-07-23 to 2021-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury [Phase 2]

See pricing